Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy.
about
HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral disseminationEffects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ARTInfection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa.Neutropenia during HIV infection: adverse consequences and remedies.The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.The role of polymorphonuclear neutrophils during HIV-1 infection.Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
P2860
Q28474374-7523CAD7-6737-44D1-A551-CDD5FB2F41B3Q33411216-E11E1CB3-2E0E-4F72-9009-52A210C5D8AAQ35991216-375DD71E-CC4C-45B4-A451-685B6B4A46B5Q36384846-EA49BE16-2A5C-4370-ADC1-8BC40850AE2CQ36919713-AFFFBEA8-0CAC-4594-BBBA-1F0FCBD7371CQ37362435-2D3B5DFA-F251-40AE-8D56-022A258D61A8Q41923884-EE7351C4-474E-48E2-9954-2EDB177E5C2CQ54533921-CD31640C-6472-4F86-B7BC-77A0EAA0EA40
P2860
Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Improvement of interleukin 2 p ...... active antiretroviral therapy.
@en
Improvement of interleukin 2 p ...... active antiretroviral therapy.
@nl
type
label
Improvement of interleukin 2 p ...... active antiretroviral therapy.
@en
Improvement of interleukin 2 p ...... active antiretroviral therapy.
@nl
prefLabel
Improvement of interleukin 2 p ...... active antiretroviral therapy.
@en
Improvement of interleukin 2 p ...... active antiretroviral therapy.
@nl
P2093
P2860
P1476
Improvement of interleukin 2 p ...... active antiretroviral therapy
@en
P2093
Alessandro Aiuti
Annamaria Mazzone
Antonello Giovannetti
Cecilia Alario
Fernando Aiuti
Francesca Mazzetta
Ivano Mezzaroma
Luigi Ruco
Maria Addesso
P2860
P304
P356
10.1046/J.1365-2141.2002.03680.X
P407
P577
2002-09-01T00:00:00Z